{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:15:24Z","timestamp":1777515324375,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006096","name":"Shiraz Transplant Research Center, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["13843"],"award-info":[{"award-number":["13843"]}],"id":[{"id":"10.13039\/501100006096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00284-022-03116-9","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T11:02:37Z","timestamp":1669719757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Altered Signatures of Plasma Inflammatory Proteins and Phonotypic Markers of NK Cells in Kidney Transplant Patients upon CMV Reactivation"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8966-1336","authenticated-orcid":false,"given":"Saeede","family":"Soleimanian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9812-8621","authenticated-orcid":false,"given":"Ramin","family":"Yaghobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2435-6277","authenticated-orcid":false,"given":"Mohammad Hossein","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4867-5686","authenticated-orcid":false,"given":"Bita","family":"Geramizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4268-1727","authenticated-orcid":false,"given":"Jamshid","family":"Roozbeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"issue":"1","key":"3116_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/ajt.16132","volume":"21","author":"G Karadkhele","year":"2021","unstructured":"Karadkhele G, Hogan J, Magua W, Zhang W, Badell IR, Mehta A et al (2021) CMV high-risk status and post-transplant outcomes in kidney transplant recipients treated with Belatacept. Am J Transplant 21(1):208\u2013221. https:\/\/doi.org\/10.1111\/ajt.16132","journal-title":"Am J Transplant"},{"issue":"9","key":"3116_CR2","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1093\/cid\/ciz1209","volume":"71","author":"M Jarque","year":"2020","unstructured":"Jarque M, Crespo E, Melilli E, Guti\u00e9rrez A, Moreso F, Guirado L et al (2020) Cellular immunity to predict the risk of cytomegalovirus infection in kidney transplantation: a prospective, interventional, multicenter clinical trial. Clin Infect Dis 71(9):2375\u20132385. https:\/\/doi.org\/10.1093\/cid\/ciz1209","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3116_CR3","first-page":"52","volume":"1","author":"S Soleimanian","year":"2022","unstructured":"Soleimanian S, Yaghobi R, Karimi MH, Geramizadeh B, Roozbeh J (2022) Loss of CCR7 expression on CD57+ CD56\/CD16+ NK cells correlates with viral load in CMV reactivated kidney transplant recipients. Iran J Kidney Dis 1(1):52\u201362","journal-title":"Iran J Kidney Dis"},{"issue":"1","key":"3116_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jcv.2012.09.017","volume":"56","author":"C Mart\u00edn-Gandul","year":"2013","unstructured":"Mart\u00edn-Gandul C, P\u00e9rez-Romero P, S\u00e1nchez M, Bernal G, Su\u00e1rez G, Sobrino M et al (2013) Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection. J J Clin Virol 56(1):13\u201318. https:\/\/doi.org\/10.1016\/j.jcv.2012.09.017","journal-title":"J J Clin Virol"},{"issue":"6","key":"3116_CR5","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1182\/blood-2007-03-078881","volume":"110","author":"CA Bolovan-Fritts","year":"2007","unstructured":"Bolovan-Fritts CA, Trout RN, Spector SA (2007) High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage. Blood 110(6):1857\u20131863. https:\/\/doi.org\/10.1182\/blood-2007-03-078881","journal-title":"Blood"},{"key":"3116_CR6","doi-asserted-by":"publisher","first-page":"101460","DOI":"10.1016\/j.trim.2021.101460","volume":"69","author":"S Soleimanian","year":"2021","unstructured":"Soleimanian S, Yaghobi R, Karimi MH, Geramizadeh B, Roozbeh J, Hossein Aghdaie M et al (2021) Circulating NKG2C + NK cell expressing CD107a\/LAMP-1 subsets at the onset of CMV reactivation in seropositive kidney transplant recipients. Transpl Immunol 69:101460. https:\/\/doi.org\/10.1016\/j.trim.2021.101460","journal-title":"Transpl Immunol"},{"issue":"4","key":"3116_CR7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jinf.2017.05.020","volume":"75","author":"JD Mena-Romo","year":"2017","unstructured":"Mena-Romo JD, P\u00e9rez Romero P, Mart\u00edn-Gandul C, Gentil M, Su\u00e1rez-Artacho G, Lage E et al (2017) CMV-specific T-cell immunity in solid organ transplant recipients at low risk of CMV infection Chronology and applicability in preemptive therapy. J Infect 75(4):336\u2013345. https:\/\/doi.org\/10.1016\/j.jinf.2017.05.020","journal-title":"J Infect"},{"issue":"8","key":"3116_CR8","doi-asserted-by":"publisher","first-page":"e0171621","DOI":"10.1128\/jcm.01716-21","volume":"60","author":"VG Hall","year":"2022","unstructured":"Hall VG, Humar A, Kumar D (2022) Utility of Cytomegalovirus Cell-Mediated Immunity Assays in Solid Organ Transplantation. J Clin Microbiol 60(8):e0171621. https:\/\/doi.org\/10.1128\/jcm.01716-21","journal-title":"J Clin Microbiol"},{"issue":"2","key":"3116_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00251-021-01245-2","volume":"74","author":"N Farzamikia","year":"2022","unstructured":"Farzamikia N, Hejazian SM, Haghi M, Hejazian SS, Zununi Vahed S, Ardalan M (2022) Evaluation of telomeric KIR genes and their association with CMV infection in kidney transplant recipients. Immunogenetics 74(2):207\u2013212. https:\/\/doi.org\/10.1007\/s00251-021-01245-2","journal-title":"Immunogenetics"},{"issue":"3","key":"3116_CR10","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1182\/blood-2008-05-157354","volume":"112","author":"TW Kuijpers","year":"2008","unstructured":"Kuijpers TW, Baars PA, Dantin C, van den Burg M, van Lier RA, Roosnek E (2008) Human NK cells can control CMV infection in the absence of T cells. Blood 112(3):914\u2013915. https:\/\/doi.org\/10.1182\/blood-2008-05-157354","journal-title":"Blood"},{"issue":"2","key":"3116_CR11","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1073\/pnas.1012356108","volume":"108","author":"A De Maria","year":"2011","unstructured":"De Maria A, Bozzano F, Cantoni C, Moretta L (2011) Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK cells as rapid producers of abundant IFN-\u03b3 on activation. Proc Natl Acad Sci U S A 108(2):728\u2013732. https:\/\/doi.org\/10.1073\/pnas.1012356108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"3116_CR12","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","volume":"104","author":"M Gum\u00e1","year":"2004","unstructured":"Gum\u00e1 M, Angulo A, Vilches C, G\u00f3mez-Lozano N, Malats N, L\u00f3pez-Botet M (2004) Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104(12):3664\u20133671. https:\/\/doi.org\/10.1182\/blood-2004-05-2058","journal-title":"Blood"},{"issue":"10","key":"3116_CR13","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.3389\/fimmu.2019.01890","volume":"23","author":"D DeWolfe","year":"2019","unstructured":"DeWolfe D, Aid M, McGann K, Ghofrani J, Geiger E, Helzer C et al (2019) NK cell contributes to the immune risk profile in kidney transplant candidates. Front Immunol 23(10):1890. https:\/\/doi.org\/10.3389\/fimmu.2019.01890","journal-title":"Front Immunol"},{"issue":"1","key":"3116_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/ajt.14900","volume":"19","author":"C Dendle","year":"2019","unstructured":"Dendle C, Gan PY, Polkinghorne KR, Ngui J, Stuart RL, Kanellis J et al (2019) Natural killer cell function predicts severe infection in kidney transplant recipients. Am J Transplant 19(1):166\u2013177. https:\/\/doi.org\/10.1111\/ajt.14900","journal-title":"Am J Transplant"},{"issue":"4","key":"3116_CR15","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli A, Michel T, Th\u00e9r\u00e9sine M, Andr\u00e8s E, Hentges F, Zimmer J (2009) CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 126(4):458\u2013465. https:\/\/doi.org\/10.1111\/j.1365-2567.2008.03027.x","journal-title":"Immunology"},{"issue":"8","key":"3116_CR16","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1073\/pnas.0409872102","volume":"102","author":"D Mavilio","year":"2005","unstructured":"Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, Marcenaro E et al (2005) Characterization of CD56\u2013\/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci U S A 102(8):2886\u20132891. https:\/\/doi.org\/10.1073\/pnas.0409872102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3116_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/ni0508-477","volume":"9","author":"K K\u00e4rre","year":"2008","unstructured":"K\u00e4rre K (2008) Natural killer cell recognition of missing self. Nat Immunol 9(5):477\u2013480. https:\/\/doi.org\/10.1038\/ni0508-477","journal-title":"Nat Immunol"},{"issue":"11","key":"3116_CR18","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1002\/eji.201444515","volume":"44","author":"N Bhatnagar","year":"2014","unstructured":"Bhatnagar N, Ahmad F, Hong HS, Eberhard J, Lu IN, Ballmaier M et al (2014) Fc\u03b3RIII (CD16)-mediated ADCC by NK cells is regulated by monocytes and Fc\u03b3RII (CD32). Eur J Immunol 44(11):3368\u20133379. https:\/\/doi.org\/10.1002\/eji.201444515","journal-title":"Eur J Immunol"},{"issue":"5","key":"3116_CR19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41423-019-0206-4","volume":"16","author":"S Sivori","year":"2019","unstructured":"Sivori S, Vacca P, Del Zotto G, Munari E, Mingari MC, Moretta L (2019) Human NK cells: surface receptors, inhibitory checkpoints, and translational applications. Cell Mol Immunol 16(5):430\u2013441. https:\/\/doi.org\/10.1038\/s41423-019-0206-4","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"3116_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/sj.bmt.1704797","volume":"35","author":"R Yaghobi","year":"2005","unstructured":"Yaghobi R, Behzad-Behbahani A, Sabahi F, Roustaee MH, Alborzi A, Ramzi M, Nourani H (2005) Comparative analysis of a double primer PCR assay with plasma, leukocytes and antigenemia for diagnosis of active human cytomegalovirus infection in bone marrow transplant patients. Bone Marrow Transplant 35(6):595\u2013599. https:\/\/doi.org\/10.1038\/sj.bmt.1704797","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"3116_CR21","first-page":"83","volume":"13","author":"A Afshari","year":"2015","unstructured":"Afshari A, Yaghobi R, Karimi MH, Darbouy M, Azarpira N, Geramizadeh B et al (2015) IL-17 mRNA expression and cytomegalovirus infection in liver transplant patients. Exp Clin Transplant 13(Suppl 1):83\u201389","journal-title":"Exp Clin Transplant"},{"issue":"2","key":"3116_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/cancers13020226","volume":"13","author":"T Pazina","year":"2021","unstructured":"Pazina T, MacFarlane AWt, Bernabei L, Dulaimi E, Kotcher R, Yam C et al (2021) Alterations of NK cell phenotype in the disease course of multiple myeloma. Cancers (Basel) 13(2):226. https:\/\/doi.org\/10.3390\/cancers13020226","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3116_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00251-015-0869-7","volume":"68","author":"P Carrillo-Bustamante","year":"2016","unstructured":"Carrillo-Bustamante P, Ke\u015fmir C, de Boer RJ (2016) The evolution of natural killer cell receptors. Immunogenetics 68(1):3\u201318. https:\/\/doi.org\/10.1007\/s00251-015-0869-7","journal-title":"Immunogenetics"},{"issue":"11","key":"3116_CR24","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3389\/fphar.2020.01309","volume":"20","author":"S Soleimanian","year":"2020","unstructured":"Soleimanian S, Yaghobi R (2020) Harnessing memory NK cell to protect against COVID-19. Front Pharmacol 20(11):1309. https:\/\/doi.org\/10.3389\/fphar.2020.01309","journal-title":"Front Pharmacol"},{"issue":"10","key":"3116_CR25","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.4049\/jimmunol.1201964","volume":"189","author":"B Foley","year":"2012","unstructured":"Foley B, Cooley S, Verneris MR, Curtsinger J, Luo X, Waller EK et al (2012) Human cytomegalovirus (CMV)-induced memory-like NKG2C+ NK cells are transplantable and expand in vivo in response to recipient CMV antigen. J Immunol 189(10):5082\u20135088. https:\/\/doi.org\/10.4049\/jimmunol.1201964","journal-title":"J Immunol"},{"issue":"4","key":"3116_CR26","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1158\/0008-5472.CAN-17-2826","volume":"78","author":"A Young","year":"2018","unstructured":"Young A, Ngiow SF, Gao Y, Patch A-M, Barkauskas DS, Messaoudene M et al (2018) A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment. C Cancer Res 78(4):1003\u20131016. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2826","journal-title":"C Cancer Res"},{"issue":"6","key":"3116_CR27","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.jaci.2020.12.648","volume":"147","author":"F Bozzano","year":"2021","unstructured":"Bozzano F, Della Chiesa M, Pelosi A, Antonini F, Ascierto ML, Del Zotto G et al (2021) HCMV-controlling NKG2C+ NK cells originate from novel circulating inflammatory precursors. J Allergy Clin Immunol 147(6):2343\u20132357. https:\/\/doi.org\/10.1016\/j.jaci.2020.12.648","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"3116_CR28","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.bbmt.2019.06.008","volume":"25","author":"JE Jang","year":"2019","unstructured":"Jang JE, Hwang DY, Chung H, Kim S-J, Eom J-I, Jeung H-K et al (2019) Early cytomegalovirus reactivation and expansion of CD56brightCD16dim\/\u2212 DNAM1+ natural killer cells are associated with antileukemia effect after haploidentical stem cell transplantation in acute leukemia. Biol Blood Marrow Transplant 25(10):2070\u20132078. https:\/\/doi.org\/10.1016\/j.bbmt.2019.06.008","journal-title":"Biol Blood Marrow Transplant"},{"key":"3116_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/5584_2015_5010","volume":"897","author":"R Rizzo","year":"2016","unstructured":"Rizzo R, Zatelli MC, Rotola A, Cassai E, Degli Uberti E, Di Luca D et al (2016) Increase in peripheral CD3\u2212 CD56 bright CD16\u2212 natural killer cells in hashimoto\u2019s thyroiditis associated with HHV-6 infection. Adv Exp Med Biol 897:113\u2013120. https:\/\/doi.org\/10.1007\/5584_2015_5010","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"3116_CR30","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.jhep.2017.01.032","volume":"66","author":"B Oliviero","year":"2017","unstructured":"Oliviero B, Mantovani S, Varchetta S, Mele D, Grossi G, Ludovisi S et al (2017) Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity. J Hepatol 66(6):1130\u20131137. https:\/\/doi.org\/10.1016\/j.jhep.2017.01.032","journal-title":"J Hepatol"},{"issue":"10","key":"3116_CR31","doi-asserted-by":"publisher","first-page":"e1033","DOI":"10.1371\/journal.pone.0001033","volume":"2","author":"J Zimmer","year":"2007","unstructured":"Zimmer J, Bausinger H, Andr\u00e8s E, Donato L, Hanau D, Hentges F et al (2007) Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiency. PLoS ONE 2(10):e1033. https:\/\/doi.org\/10.1371\/journal.pone.0001033","journal-title":"PLoS ONE"},{"issue":"15","key":"3116_CR32","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1073\/pnas.0601335103","volume":"103","author":"B Bielekova","year":"2006","unstructured":"Bielekova B, Catalfamo M, Reichert-Scrivner S, Packer A, Cerna M, Waldmann TA et al (2006) Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2R\u03b1-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci U S A 103(15):5941\u20135946. https:\/\/doi.org\/10.1073\/pnas.0601335103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3116_CR33","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3389\/fimmu.2013.00422","volume":"9","author":"CM Nielsen","year":"2013","unstructured":"Nielsen CM, White MJ, Goodier MR, Riley EM (2013) Functional significance of CD57 expression on human NK cells and relevance to disease. Front Immunol 9(4):422. https:\/\/doi.org\/10.3389\/fimmu.2013.00422","journal-title":"Front Immunol"},{"issue":"1","key":"3116_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4049\/jimmunol.179.1.89","volume":"179","author":"A Chan","year":"2007","unstructured":"Chan A, Hong DL, Atzberger A, Kollnberger S, Filer AD, Buckley CD et al (2007) CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J Immunol 179(1):89\u201394. https:\/\/doi.org\/10.4049\/jimmunol.179.1.89","journal-title":"J Immunol"},{"issue":"19","key":"3116_CR35","first-page":"3865","volume":"116","author":"S Lopez-Verg\u00e8s","year":"2010","unstructured":"Lopez-Verg\u00e8s S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H et al (2010) CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood, J Am Soc Hematol 116(19):3865\u20133874","journal-title":"Blood, J Am Soc Hematol"},{"issue":"19","key":"3116_CR36","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1182\/blood-2010-04-281675","volume":"116","author":"NK Bj\u00f6rkstr\u00f6m","year":"2010","unstructured":"Bj\u00f6rkstr\u00f6m NK, Riese P, Heuts F, Andersson S, Fauriat C, Ivarsson MA et al (2010) Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116(19):3853\u20133864. https:\/\/doi.org\/10.1182\/blood-2010-04-281675","journal-title":"Blood"},{"issue":"5","key":"3116_CR37","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1038\/ncomms6639","volume":"4","author":"TH Ali","year":"2014","unstructured":"Ali TH, Pisanti S, Ciaglia E, Mortarini R, Anichini A, Garofalo C et al (2014) Enrichment of CD56 dim KIR+ CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients. Nat Commun 4(5):5639. https:\/\/doi.org\/10.1038\/ncomms6639","journal-title":"Nat Commun"},{"key":"3116_CR38","doi-asserted-by":"publisher","first-page":"101460","DOI":"10.1016\/j.trim.2021.101460","volume":"69","author":"S Soleimanian","year":"2021","unstructured":"Soleimanian S, Yaghobi R, Karimi MH, Geramizadeh B, Roozbeh J, Aghdaie MH et al (2021) Circulating NKG2C+ NK cell expressing CD107a\/LAMP-1 subsets at the onset of CMV reactivation in seropositive kidney transplant recipients. Transpl Immunol 69:101460. https:\/\/doi.org\/10.1016\/j.trim.2021.101460","journal-title":"Transpl Immunol"},{"issue":"6","key":"3116_CR39","doi-asserted-by":"publisher","first-page":"721","DOI":"10.18502\/ijaai.v20i6.8023","volume":"20","author":"S Soleimanian","year":"2021","unstructured":"Soleimanian S, Yaghobi R, Karimi MH, Geramizadeh B, Roozbeh J (2021) The direct influence of cytomegalovirus lysate on the natural killer cell receptor repertoire. Iran J Allergy Asthma Immunol 20(6):721\u2013733. https:\/\/doi.org\/10.18502\/ijaai.v20i6.8023","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"10","key":"3116_CR40","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.3389\/fimmu.2019.02087","volume":"4","author":"SE Clark","year":"2019","unstructured":"Clark SE, Burrack KS, Jameson SC, Hamilton SE, Lenz LL (2019) NK cell IL-10 production requires IL-15 and IL-10 driven STAT3 activation. Front Immunol 4(10):2087. https:\/\/doi.org\/10.3389\/fimmu.2019.02087","journal-title":"Front Immunol"},{"issue":"2","key":"3116_CR41","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/eji.201747134","volume":"48","author":"YLT Chan","year":"2018","unstructured":"Chan YLT, Zuo J, Inman C, Croft W, Begum J, Croudace J et al (2018) NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD. Eur J Immunol 48(2):316\u2013329. https:\/\/doi.org\/10.1002\/eji.201747134","journal-title":"Eur J Immunol"},{"issue":"6","key":"3116_CR42","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.4049\/jimmunol.1101021","volume":"187","author":"MA Stacey","year":"2011","unstructured":"Stacey MA, Marsden M, Wang EC, Wilkinson GW, Humphreys IR (2011) IL-10 restricts activation-induced death of NK cells during acute murine cytomegalovirus infection. J Immunol 187(6):2944\u20132952. https:\/\/doi.org\/10.4049\/jimmunol.1101021","journal-title":"J Immunol"},{"issue":"1\u20132","key":"3116_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","volume":"294","author":"G Alter","year":"2004","unstructured":"Alter G, Malenfant JM, Altfeld M (2004) CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294(1\u20132):15\u201322. https:\/\/doi.org\/10.1016\/j.jim.2004.08.008","journal-title":"J Immunol Methods"},{"issue":"2","key":"3116_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3390\/microorganisms8020289","volume":"8","author":"T Rabe","year":"2020","unstructured":"Rabe T, Lazar K, Cambronero C, Goelz R, Hamprecht K (2020) Human cytomegalovirus (HCMV) reactivation in the mammary gland induces a proinflammatory cytokine shift in breast milk. Microorganisms 8(2):289. https:\/\/doi.org\/10.3390\/microorganisms8020289","journal-title":"Microorganisms"},{"issue":"2","key":"3116_CR45","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/JLB.2AB0418-158RR","volume":"106","author":"KA Holder","year":"2019","unstructured":"Holder KA, Grant MD (2019) Human cytomegalovirus IL-10 augments NK cell cytotoxicity. J Leukoc Biol 106(2):447\u2013454. https:\/\/doi.org\/10.1002\/JLB.2AB0418-158RR","journal-title":"J Leukoc Biol"},{"issue":"2","key":"3116_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/cells1020035","volume":"1","author":"TM Nowacki","year":"2012","unstructured":"Nowacki TM, Bettenworth D, Ross M, Heidemann J, Lehmann PV, L\u00fcgering A (2012) Cytomegalovirus (CMV)-specific perforin and granzyme B ELISPOT assays detect reactivation of CMV infection in inflammatory bowel disease. Cells 1(2):35\u201350","journal-title":"Cells"},{"issue":"3","key":"3116_CR47","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1086\/314629","volume":"179","author":"PC Wever","year":"1999","unstructured":"Wever PC, Spaeny LH, van der Vliet HJ, Rentenaar RJ, Wolbink AM, Surachno J et al (1999) Expression of granzyme\u2010B during primary cytomegalovirus infection after renal transplantation. J Infect Dis 179(3):693\u2013696. https:\/\/doi.org\/10.1086\/314629","journal-title":"J Infect Dis"},{"issue":"3","key":"3116_CR48","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1399-0039.2008.01218.x","volume":"73","author":"A Krensky","year":"2009","unstructured":"Krensky A, Clayberger C (2009) Biology and clinical relevance of granulysin. Tissue Antigens 73(3):193\u2013198. https:\/\/doi.org\/10.1111\/j.1399-0039.2008.01218.x","journal-title":"Tissue Antigens"},{"issue":"1","key":"3116_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/s0198-8859(00)00228-7","volume":"62","author":"MM Sarwal","year":"2001","unstructured":"Sarwal MM, Jani A, Chang S, Huie P, Wang Z, Salvatierra O Jr et al (2001) Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation. Hum Immunol 62(1):21\u201331. https:\/\/doi.org\/10.1016\/s0198-8859(00)00228-7","journal-title":"Hum Immunol"},{"issue":"11","key":"3116_CR50","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1182\/blood-2009-08-238469","volume":"115","author":"C Fauriat","year":"2010","unstructured":"Fauriat C, Long EO, Ljunggren H-G, Bryceson YT (2010) Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115(11):2167\u20132176. https:\/\/doi.org\/10.1182\/blood-2009-08-238469","journal-title":"Blood"},{"issue":"1","key":"3116_CR51","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41390-020-01248-x","volume":"90","author":"GM Froeschle","year":"2021","unstructured":"Froeschle GM, Bedke T, Boettcher M, Huber S, Singer D, Ebenebe CU (2021) T cell cytokines in the diagnostic of early-onset sepsis. Pediatr Res 90(1):191\u2013196. https:\/\/doi.org\/10.1038\/s41390-020-01248-x","journal-title":"Pediatr Res"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-022-03116-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-022-03116-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-022-03116-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T15:11:07Z","timestamp":1673363467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-022-03116-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["3116"],"URL":"https:\/\/doi.org\/10.1007\/s00284-022-03116-9","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]},"assertion":[{"value":"20 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no financial conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The studies involving human participants were reviewed and approved by the local Ethics Committee of Shiraz University of Medical Sciences (IR.SUMS.REC. 1396. S289).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"9"}}